796 related articles for article (PubMed ID: 17002866)
1. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
Shibuya M
J Biochem Mol Biol; 2006 Sep; 39(5):469-78. PubMed ID: 17002866
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E.
Shibuya M
Endothelium; 2006; 13(2):63-9. PubMed ID: 16728325
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.
Shibuya M; Claesson-Welsh L
Exp Cell Res; 2006 Mar; 312(5):549-60. PubMed ID: 16336962
[TBL] [Abstract][Full Text] [Related]
4. VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases.
Shibuya M
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):135-44. PubMed ID: 25772179
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases.
Shibuya M
J Biochem; 2013 Jan; 153(1):13-9. PubMed ID: 23172303
[TBL] [Abstract][Full Text] [Related]
6. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice.
Hiratsuka S; Nakao K; Nakamura K; Katsuki M; Maru Y; Shibuya M
Mol Cell Biol; 2005 Jan; 25(1):346-54. PubMed ID: 15601855
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
8. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
9. VEGFR1 and VEGFR2 in Alzheimer's Disease.
Harris R; Miners JS; Allen S; Love S
J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
[TBL] [Abstract][Full Text] [Related]
10. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
Breier G; Clauss M; Risau W
Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
[TBL] [Abstract][Full Text] [Related]
11. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.
Li B; Sharpe EE; Maupin AB; Teleron AA; Pyle AL; Carmeliet P; Young PP
FASEB J; 2006 Jul; 20(9):1495-7. PubMed ID: 16754748
[TBL] [Abstract][Full Text] [Related]
12. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
14. Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2.
Thalgott JH; Dos-Santos-Luis D; Hosman AE; Martin S; Lamandé N; Bracquart D; Srun S; Galaris G; de Boer HC; Tual-Chalot S; Kroon S; Arthur HM; Cao Y; Snijder RJ; Disch F; Mager JJ; Rabelink TJ; Mummery CL; Raymond K; Lebrin F
Circulation; 2018 Dec; 138(23):2698-2712. PubMed ID: 30571259
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.
Hiratsuka S; Maru Y; Okada A; Seiki M; Noda T; Shibuya M
Cancer Res; 2001 Feb; 61(3):1207-13. PubMed ID: 11221852
[TBL] [Abstract][Full Text] [Related]
16. Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
Sadremomtaz A; Kobarfard F; Mansouri K; Mirzanejad L; Asghari SM
J Recept Signal Transduct Res; 2018; 38(5-6):432-441. PubMed ID: 30929546
[TBL] [Abstract][Full Text] [Related]
17. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.
Zachary I; Gliki G
Cardiovasc Res; 2001 Feb; 49(3):568-81. PubMed ID: 11166270
[TBL] [Abstract][Full Text] [Related]
18. [Non-angiogenic functions of vascular endothelial growth factor].
Xiong Y; Han XF; Luo JC
Sheng Li Ke Xue Jin Zhan; 2011 Feb; 42(1):6-10. PubMed ID: 21595180
[TBL] [Abstract][Full Text] [Related]
19. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
[TBL] [Abstract][Full Text] [Related]
20. A chemically defined culture of VEGFR2+ cells derived from embryonic stem cells reveals the role of VEGFR1 in tuning the threshold for VEGF in developing endothelial cells.
Hirashima M; Ogawa M; Nishikawa S; Matsumura K; Kawasaki K; Shibuya M; Nishikawa S
Blood; 2003 Mar; 101(6):2261-7. PubMed ID: 12406893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
